Eli Lilly stock (NYSE: LLY) will report its Q3 results on Wednesday, October 30. The pharmaceutical giant is expected to garner $12.1 billion in sales and $1.45 in adjusted earnings per share, per the ...
Weight loss drugs generated about $10 billion for Lilly in the most recent quarter. One particular hurdle for some patients, however, has been the price of these products. Medicare so far hasn't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback